Skip to main content
. 2021 Jun 30;33(3):352–363. doi: 10.21147/j.issn.1000-9604.2021.03.07

Figure 1.

Figure 1

Flowchart of study population from multicenter population-based liver cancer screening. HBsAg, hepatitis B surface antigen; HCC, hepatocellular carcinoma; AFP, α-fetoprotein; DCP, des-γ-carboxy-prothrombin; GGT, γ-glutamyl-transpeptidase; PLT, platelet; WBC, white blood cell.